DR. THOMAS V. CLANCY, MD

Plain English
This research studied the impact of genetic counselling on individuals at risk for familial colorectal cancer (fCRC), including those with genetic syndromes like Lynch syndrome. Out of 82 participants, those who received genetic counselling showed notable improvements in feelings of empowerment, reduced anxiety (35%), and lower depression (40%) compared to those who only received standard care. This is important because it means that genetic counselling can lead to better mental health and coping skills for people facing these serious health risks. Who this helps: This research benefits patients at risk for familial colorectal cancer and their families.

Plain English
This study focuses on genetic counseling, which helps people understand the impact of genetics on their health. It analyzed various research studies to find out how effective genetic counseling is, while identifying challenges caused by differences in study methods and sizes. The findings suggest that using meta-analyses, which combine results from multiple studies, can improve our understanding of genetic counseling's effectiveness, making it easier to guide treatment and policy decisions. Who this helps: Patients and healthcare providers involved in genetic counseling.

Plain English
This study examined how often patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) are used in trials of advanced therapies for rare diseases. Out of 100 trials analyzed, only 37% included PROs, while a variety of measures like quality of life and health-related quality of life were identified. The findings emphasize the need to better incorporate patient experiences into research to ensure that treatment development truly reflects their needs. Who this helps: This helps patients with rare diseases by ensuring their voices and experiences are considered in treatment development.

Plain English
This study looked at how effective genetic counseling is for people at risk of familial colorectal cancer. The researchers found that genetic counseling leads to small but meaningful improvements in individuals' feelings about their risk, their understanding of the disease, and their behaviors related to health, with an overall positive effect size of 0.234. This is important because it shows that genetic counseling can help people better manage their health and make informed decisions, particularly for those with family histories of this cancer. Who this helps: Patients with a family history of colorectal cancer and their families.

Plain English
This study looked at how well surgical residents make decisions about whether to operate and how confident they feel about those decisions. Sixty residents were tested with scenarios related to conditions like appendicitis and gallbladder issues, with an average score of 66.3%. Senior residents performed better than juniors, scoring 68.7% compared to 63.9%, and felt more confident about their decisions. Who this helps: This benefits surgical residents and their trainers by highlighting areas for improvement in preoperative decision-making.

Plain English
This study looked at using a new treatment called LTX-315 along with immune therapy to help patients with advanced soft tissue sarcoma, a type of cancer. Out of six patients treated, four went on to receive the follow-up therapy, with one patient remaining stable for 208 days and showing signs of a positive immune response. This is important because it shows that this combined approach can activate the immune system and potentially slow down cancer progression when other treatments have failed. Who this helps: This benefits patients with metastatic soft tissue sarcoma seeking new treatment options.

Plain English
This study looked at how specific genes (HLA genes) in tumors and nearby healthy tissue can help us understand how the immune system responds to cancer. Researchers found a new method to accurately identify these genes and measure their activity, revealing that the way cancer cells present themselves to immune cells can vary significantly; for example, the new genotyping method outperformed previous techniques in classifying HLA genes in breast cancer samples. Understanding these interactions is crucial because it can inform treatment options and improve immunotherapy outcomes for patients. Who this helps: This helps patients with cancer and their doctors by providing better insights into personalized treatment options.

Plain English
This paper looks at how well certain parts of the SARS-CoV-2 virus trigger an immune response in the body, using information gathered through artificial intelligence. Researchers found that some specific viral fragments, or epitopes, did lead to a strong T cell response, confirming the predictions made by their AI model. This is important because it can help guide the development of better vaccines and treatments for COVID-19. Who this helps: This helps patients and vaccine developers.

Plain English
This study examined a new type of cancer vaccine made from patients' own melanoma cells, which were modified to produce a protein that helps stimulate the immune system. Researchers treated 61 patients with advanced melanoma and found that the vaccine was safe and led to 39.3% of patients showing disease control, with stage III patients surviving a median of 71.1 months and stage IV patients 14.9 months. This is significant because it shows that this vaccine can boost the immune response against melanoma, potentially improving treatment outcomes. Who this helps: This benefits patients with stage III and IV melanoma.

Plain English
In this study, researchers looked at specific types of immune cells called CD8 T cells from fluid collected in the chest of advanced lung cancer patients. They discovered that certain T cells, which are linked to fighting the tumor, tended to show higher levels of markers called PD-1 and 4-1BB, and patients with more of these cells had a better chance of surviving; for instance, patients with high PD-1/4-1BB expression had better outcomes compared to others. This finding is important because it could help develop new treatments that use the patients' own immune cells to target their cancer more effectively. Who this helps: This helps lung cancer patients by identifying markers that could guide more effective immunotherapy treatments.

Plain English
This study looked at natural killer (NK) cells, which are important immune cells that help fight cancer, by creating a detailed map showing how they behave in healthy people and in various tumors. Researchers examined data from 427 patients with seven different types of cancer and found that a specific type of stressed NK cell was common across tumors and linked to worse outcomes, while a more active NK cell type was linked to better outcomes. This information could help in developing targeted NK cell therapies that improve treatment effectiveness. Who this helps: This helps patients with cancer by providing insights into potential new therapies.

Plain English
This research studied a new way to predict B cell epitopes, which are parts of proteins that can trigger an immune response, important for vaccine development. The researchers created a novel method using a new type of data representation that improved prediction accuracy, identifying more than 70% of known epitopes on the SARS-CoV-2 spike protein that weren’t part of the training data. This improvement is significant because it enhances the tools available for designing vaccines and diagnostics, making the process faster and cheaper. Who this helps: This helps researchers and vaccine developers in creating more effective vaccines and diagnostic tools.

Plain English
This study developed a new tool called PepPPO to help identify how well certain peptides can bind to MHC Class I proteins, which play a key role in helping the immune system target tumors. Using this tool, researchers successfully characterized binding patterns for about 10,000 human MHC Class I proteins and found that the results closely matched earlier laboratory tests, proving the tool's accuracy. This advancement allows for faster and cheaper screening of new cancer treatments compared to older methods. Who this helps: This benefits researchers and doctors working on cancer immunotherapy.

Plain English
This study looked at a new treatment for advanced melanoma by combining a telomerase-based vaccine with the drug pembrolizumab. Out of 30 patients, the treatment was found to be safe, with only 20% experiencing serious side effects, and showed promising results: patients lived an average of 18.9 months without their cancer worsening, 86.7% were alive after one year, and 56.7% had a positive response to the treatment. This matters because it offers a potential new option for patients whose tumors are less responsive to conventional therapies. Who this helps: Patients with advanced melanoma.

Plain English
This study looked at how well COVID-19 vaccines work in patients who have received hematopoietic stem cell transplants (HSCT). It found that although only 37% of the 48 patients had strong antibody levels, nearly all showed a strong T cell response, with 90% of patients reacting to key virus components. This is important because it indicates that T cell responses can protect HSCT recipients from severe COVID-19, even if their antibody levels are low. Who this helps: This helps patients who have undergone stem cell transplants.

Plain English
This study looked at CD8 T cells that infiltrate tumors in patients with non-small cell lung cancer (NSCLC) to better understand how these immune cells recognize cancer-related targets. Researchers analyzed nearly 7,000 CD8 T cells from three lung cancer samples and found a specific group of exhausted T cells that respond to both a known cancer/testis antigen and multiple new cancer-specific antigens. This understanding is important because it can help develop more effective immunotherapies for lung cancer by targeting the right antigens that stimulate the immune response. Who this helps: Patients with non-small cell lung cancer.

Plain English
This study focused on rare cancers known as gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to understand their growth and how they interact with the immune system. Researchers analyzed the genes activated in tumor and immune cells from patients and found that GEP-NET cells show characteristics similar to healthy gastrointestinal cells. They discovered that although these tumors express some genes related to immune suppression, there are other immune checkpoints present in the tumor environment that could be targeted for new treatments. Who this helps: This research benefits patients with gastroenteropancreatic neuroendocrine tumors by paving the way for more tailored and effective therapies.

Plain English
This study looked at how certain immune properties in tumor environments affect the success of a cancer treatment called immune checkpoint inhibition (ICI) in patients with sarcomas, which are tumors in bones and connective tissues. Researchers analyzed samples from 31 sarcoma patients treated with pembrolizumab and found that patients with high-quality neoantigens (specific proteins that tumors create) and a mix of immune cells like T cells and B cells experienced better survival without disease progression. Specifically, those with both CD8+ T cells and neoantigens had improved survival compared to those with just one or the other, highlighting their combined importance for patient outcomes. Who this helps: This research benefits sarcoma patients by potentially guiding better treatment strategies.

Plain English
This study used artificial intelligence to find specific parts of the SARS-CoV-2 virus that can trigger an immune response, focusing on T cells, which are crucial for fighting infections. Researchers identified 59 promising T cell targets, with 33 of them being new discoveries that weren't documented before, mostly coming from non-spike areas of the virus. This research is significant because it opens the door for creating more effective T cell vaccines against COVID-19. Who this helps: This benefits vaccine developers and patients looking for improved COVID-19 vaccines.

Plain English
This study looked at how people who use drugs respond to COVID-19 vaccines, focusing on their T-cell immunity. The researchers found that these individuals did not have higher levels of T-cells that react to SARS-CoV-2 before vaccination, but after receiving the vaccine, they developed strong T-cell responses similar to those of people who do not use drugs. This is important because it shows that even in high-risk groups, vaccines can effectively boost the immune system against COVID-19. Who this helps: This helps patients who use drugs by ensuring they can effectively respond to COVID-19 vaccinations.

Plain English
This study looked at how genetic testing can improve the diagnosis of certain cancers, particularly those linked to a condition called Lynch syndrome. Out of nearly 3,700 tumor samples tested, about 18% showed a problem related to mismatch repair, with colorectal and endometrial cancers having different rates of these issues. This research is important because better diagnosis can lead to more effective treatment plans for patients at risk of Lynch syndrome, which can significantly affect their health outcomes. Who this helps: Patients with colorectal and endometrial cancers and their healthcare providers.

Plain English
This study looked at 297 women who had surgery to reduce their risk of breast cancer by removing both breasts and then having breast reconstruction. It found that women diagnosed with cancer during surgery reported lower satisfaction with their breasts and sexual wellbeing compared to those without cancer. Importantly, women with higher anxiety before the surgery felt less satisfied with their overall emotional wellbeing afterward, even though they were satisfied with how they looked after reconstruction. Who this helps: This information benefits both patients and doctors by improving pre-surgery counseling and understanding of patient experiences.

Plain English
This study looked at how effective genetic testing has been over 30 years for identifying people at high risk of breast and colorectal cancers. Researchers found 2,082 individuals with rare genetic changes that increase cancer risk, which led to 3,216 follow-up tests for their family members, identifying 1,999 cases related to the BRCA genes and 731 linked to Lynch Syndrome. These results highlight the importance of genetic testing in preventing and detecting cancer early and guiding treatment for families at risk. Who this helps: Patients with a family history of breast and colorectal cancers and their relatives.

Plain English
Researchers studied how to better identify specific genetic variations in the HLA region, particularly for cancer patients, using advanced DNA sequencing methods. They tested this new approach on samples from 10 metastatic melanoma patients and found it was 100% accurate in determining the HLA types, with one new HLA variant identified and an overall success rate of 91% in detecting variations. This is important because understanding these genetic variations can improve cancer treatment by helping to tailor therapies according to each patient's immune response. Who this helps: This helps cancer patients by providing more personalized treatment options.

Plain English
This study looked at whether race affects the chances of non-White patients getting liver surgery for colorectal cancer that has spread to the liver. Researchers analyzed data from over 27,000 patients and found that non-White patients were 13% less likely to receive this surgery compared to White patients, even in hospitals known for doing a high volume of these surgeries. This matters because it highlights ongoing inequalities in healthcare access based on race, affecting treatment outcomes for certain groups. Who this helps: This helps patients, particularly non-White individuals with colorectal liver metastasis.

Plain English
This study looked at how 13 Saudi patients with Long QT Syndrome view their health conditions in the context of their Islamic beliefs. It found that patients’ unique interpretations of their faith significantly impacted their coping strategies and medical choices, more than their actual religious beliefs did. This matters because when health professionals provide clear and detailed information, it can help patients make better decisions about their health while respecting their religious views. Who this helps: This helps patients with genetic disorders and the healthcare providers who support them.

Plain English
This study looked at the experiences of 445 women at high risk of breast cancer who chose to have both breasts removed and reconstructed, specifically comparing those with breast cancer at the time of surgery to those without. Researchers found that women with breast cancer needed more surgeries to complete their reconstruction—about four procedures compared to two for women without cancer—but overall complication rates and the need for emergency surgeries were similar between the two groups. This research highlights that while risk-reducing mastectomy is generally safe and effective, patients should be aware that they may require multiple surgeries. Who this helps: This information benefits women at high risk for breast cancer who are considering preventive surgery.

Plain English
This study looked at how visiting more than one cancer hospital affects the chances of patients with colorectal cancer that has spread to the liver getting surgery to remove those liver tumors. Researchers found that only 11.1% of patients chose to visit more than one hospital, but those who did were 27% more likely to have the surgery. Importantly, while Black patients were less likely to seek care at multiple hospitals, once they did, their chances of getting the surgery were similar to those of White patients. Who this helps: This benefits patients with colorectal cancer and their families by highlighting the importance of seeking multiple opinions for better treatment options.

Plain English
This study looked at the immune response of T cells to different versions of the SARS-CoV-2 virus, especially focusing on the variants that have raised concerns, like Omicron. Researchers found that T cell immunity remains strong even as the virus changes, with a high level of similarity in T cell targets across the mutations of these variants. This finding is important because it can help create better vaccines and diagnostic tools that will work effectively against both current and future variants of the virus. Who this helps: This helps patients by potentially improving COVID-19 vaccines and treatments.

Plain English
This study looked at high endothelial venules (HEVs), which are special blood vessels that help immune cells move from the blood into lymph nodes. The researchers found that HEVs are also created in various organs affected by chronic inflammation and cancer. They emphasize the potential of HEVs as beneficial pathways to improve cancer treatments, particularly with new immunotherapies that depend on these vessels to guide immune cells to tumors. Who this helps: This research benefits patients with cancer and immune-related diseases.

Plain English
This study looked at combining a new cancer vaccine called UV1 with a drug called ipilimumab in patients with advanced melanoma. It involved 12 patients, and the results showed that 91% had an immune response to the vaccine, with an average progression-free survival of 6.7 months and an overall survival of 66.3 months. This finding is important because it shows that this combination treatment can help patients even when typical predictive measures for treatment success do not indicate it would work. Who this helps: This benefits patients with metastatic melanoma.

Plain English
This study examined the effects of neoadjuvant chemotherapy (a treatment given before surgery) on the immune environment of pancreatic cancer tumors. Researchers analyzed tissue samples from 36 tumors treated with neoadjuvant chemotherapy and compared them to samples from 30 tumors that only had surgery. They found that 72% of the tumors treated with chemotherapy had a beneficial immune profile that included a higher presence of T cells, which is linked to better patient survival rates. Who this helps: This benefits patients with pancreatic cancer by improving treatment outcomes.

Plain English
This study looked at how often a specific DNA repair problem, called mismatch repair deficiency, occurs in women with ovarian cancer, particularly those at high risk for Lynch syndrome, a genetic condition linked to certain cancers. Out of 261 women tested, 27 (about 10.3%) had this DNA issue, and further tests showed that 9 out of 33 (27%) of those screened for Lynch syndrome had harmful genetic changes. Understanding who has mismatch repair deficiency is crucial because it helps identify women at higher risk for cancer, allowing for better prevention and treatment options. Who this helps: This helps patients with ovarian cancer and their families.

Plain English
This study looked at the types and locations of immune cells, specifically myeloid cells, in pancreatic cancer tumors and how they impact patient survival. Researchers examined 305 tumor samples and found that patients with high levels of certain types of immune cells had worse outcomes; for instance, a high presence of specific immunosuppressive cells was linked to decreased survival rates. Understanding how these immune cells are distributed around tumors can help improve the way doctors assess and treat pancreatic cancer. Who this helps: This helps doctors and researchers make better treatment decisions for pancreatic cancer patients.

Plain English
The study looked at how many women at high risk for breast cancer chose to have a preventive double mastectomy over time. Out of nearly 7,200 women tracked, only 6.2% (451 women) opted for the surgery, with the likelihood varying significantly based on genetic risk factors. For instance, 47.7% of women with BRCA gene mutations chose the surgery, compared to just 2.9% of those with a slightly lower risk level. Who this helps: This information helps women at high risk for breast cancer make informed decisions regarding their preventive options.

Plain English
Researchers studied a new care plan for patients with stomach cancer who were undergoing surgery. They found that after implementing this fast-track process in July 2018, patients’ hospital stays were shorter—an average of 6 days instead of 9 days—without increasing complications or readmissions. This matters because it means patients can recover faster and spend less time in the hospital while still receiving safe care. Who this helps: This helps patients with gastric cancer and their families.

Plain English
This study reviewed 28 previous research papers to understand how congenital heart disease (CHD) affects the emotional and social development of young children who have had heart surgery. It found that many of these children show signs of emotional and behavioral difficulties, particularly those with more severe forms of CHD. Early identification and monitoring of these issues is important for providing necessary support and interventions to help them develop better. Who this helps: This benefits young patients with congenital heart disease and their families.

Plain English
This study examined how testing for certain genetic mutations (BRCA1/2) has changed over 12 years in women diagnosed with non-mucinous ovarian cancer in the North West of England. Out of 1,081 women tested, 222 (20.5%) had harmful mutations, and the rate of testing increased significantly over time. Mainstream testing helps identify patients quickly for treatment with PARP inhibitors, but fewer first-degree relatives were tested when using this method compared to genetics clinics, highlighting a need for better family testing practices. Who this helps: This helps ovarian cancer patients and their families.

Plain English
This study looked at how peer mentoring affects medical residents during their training, particularly regarding their mental health and professional skills. The review of nine studies found that residents benefit significantly from support and motivation provided by their peers, leading to increased satisfaction in their training programs. This is important because a supportive environment can help prevent burnout and improve the overall quality of medical education. Who this helps: This helps medical residents and their training programs.

Plain English
This study used artificial intelligence to create plans for universal vaccines against COVID-19 by mapping parts of the virus that can trigger an immune response. Researchers examined 3,400 different virus sequences and identified key areas called "epitope hotspots" that are likely to produce a strong immune reaction without causing harmful side effects. They found a combination of these hotspots that can effectively protect a diverse range of people. Who this helps: This helps vaccine developers and ultimately patients around the world by identifying more effective vaccine designs.

Plain English
This study looked at how certain immune cells called tumor-associated macrophages (TAMs) behave in pancreatic cancer. The researchers found that these TAMs had reduced ability to clear cancer cells compared to normal immune cells. By increasing the levels of a protein called VentX in these TAMs, they were able to enhance their ability to fight the cancer, which could lead to better outcomes for patients. Who this helps: This research benefits pancreatic cancer patients by providing insights into potential new treatment strategies.

Plain English
This study looked at how well doctors are identifying patients with pancreatic cancer who might have inherited genetic mutations that put them at risk. Out of 400 patients studied, 113 (about 28%) were eligible for genetic consultations, but only 10 (8.8%) were actually referred for this important testing. This matters because finding these mutations could help patients and their families make better health choices. Who this helps: This helps patients and their families by improving awareness and access to genetic testing.

Plain English
This study looked at a new tool called NeoMutate, designed to improve the detection of cancer mutations in genetic testing. Researchers tested NeoMutate by analyzing over 10,000 real cancer mutations, and found it did a much better job identifying these mutations compared to other existing methods. This improvement in accuracy can lead to better diagnosis and treatment plans for cancer patients. Who this helps: This helps cancer patients and doctors making treatment decisions.

Plain English
This study focused on improving the way we identify certain genes, known as HLA alleles, that are important for guiding treatments and organ transplants. The researchers developed a new method that analyzed genetic data, achieving accuracy rates of 98.73% for Class I alleles and 96.37% for Class II alleles, which is better than current methods. This improvement in accuracy can lead to better matching of patients for transplants and personalized medicine. Who this helps: This helps patients needing organ transplants and targeted therapies.

Plain English
This study looked at how diverse natural killer (NK) cells, a part of our immune system, maintain their variety and functionality. Researchers found that different types of NK cells grow at different rates and that this affects their ability to fight off infections. Specifically, about half of the slowly growing NK cells showed better performance due to certain genetic activity related to immune responses, while rapidly growing cells lost some functionality and showed stress signs. Who this helps: This benefits patients, particularly those with immune-related diseases or conditions where NK cell function is crucial.

Plain English
This study explored how natural killer (NK) cells, a type of immune cell, become better at responding to threats when trained by specific signals. Researchers found that these educated NK cells store a critical enzyme called granzyme B in special compartments called secretory lysosomes, which helps them function effectively. When certain signals are disrupted, NK cells showed increased granzyme B levels and better response capabilities, similar to educated NK cells. Who this helps: This research benefits patients needing improved immune responses, especially in cancer treatments.

Plain English
This study looked at how surgery affects survival rates for patients with metastatic pancreatic neuroendocrine tumors (PNETs). It found that patients who had their primary tumor removed through a procedure called pancreaticoduodenectomy, or had surgery to remove metastatic tumors, lived longer compared to those who had no surgery. Specifically, both types of surgery were linked to improved survival times, indicating a clear benefit for patients who undergo these procedures. Who this helps: This helps patients with metastatic pancreatic neuroendocrine tumors and their doctors in making treatment decisions.